{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:45:04Z","timestamp":1789728304538,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100017552","name":"Zhejiang Association for Science and Technology","doi-asserted-by":"publisher","award":["2024C03152"],"award-info":[{"award-number":["2024C03152"]}],"id":[{"id":"10.13039\/501100017552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073560"],"award-info":[{"award-number":["82073560"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Urea cycle disorders (UCDs) are a group of rare genetic metabolic disorders characterized by hyperammonemia, which can lead to neurological damage, systemic complications, and even death. Understanding UCDs\u2019 clinical features and progression in the Chinese population will fill research gaps and benefit patients globally.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective study evaluated the clinical, biochemical, genetic characteristics, and long-term outcomes in 101 Chinese patients with six subtypes of UCDs between 2007 and 2024. Data were collected from medical records and analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The overall survival rate was 93.0% among UCD patients. An equal gender ratio was observed in ornithine transcarbamylase deficiency. Newborn screening (NBS) was conducted in this cohort, and 57.0% of patients were diagnosed through NBS. Neurological and gastrointestinal symptoms were the most common. Symptoms often appeared within the first year, especially in the first month. Arginine was the most frequently used treatment, with glycerol phenylbutyrate often used as a nitrogen scavenger in severe cases. Biochemical analysis showed subtype-specific differences, including notable declines in leucine and glycine on low-protein diets. Genetic analysis revealed a wide distribution of mutations, with few hotspots and 17 newly identified mutations. Clinically diagnosed patients had worse outcomes than those diagnosed via newborn screening.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study is the first to describe the clinical features and long-term outcomes of UCDs in a large sample of Chinese patients, highlighting the importance of newborn screening for early diagnosis and improved treatment outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03985-w","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T15:46:32Z","timestamp":1755099992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical characteristics and long-term outcomes of 101 patients with urea cycle disorders in China"],"prefix":"10.1186","volume":"20","author":[{"given":"Ziyan","family":"Cen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingwei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1124-7044","authenticated-orcid":false,"given":"Xinwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"issue":"3","key":"3985_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/0969141320973690","volume":"28","author":"K Deng","year":"2021","unstructured":"Deng K, Zhu J, Yu E, Xiang L, Yuan X, Yao Y, Li X, Liu H. Incidence of inborn errors of metabolism detected by tandem mass spectrometry in China: a census of over seven million newborns between 2016 and 2017. J Med Screen. 2021;28(3):223\u20139. https:\/\/doi.org\/10.1177\/0969141320973690.","journal-title":"J Med Screen"},{"issue":"1","key":"3985_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0513-0","volume":"11","author":"MC Husson","year":"2016","unstructured":"Husson MC, Schiff M, Fouilhoux A, Cano A, Dobbelaere D, Brassier A, Mention K, Arnoux JB, Feillet F, Chabrol B, et al. Efficacy and safety of i.v. sodium benzoate in urea cycle disorders: a multicentre retrospective study. Orphanet J Rare Dis. 2016;11(1): 127. https:\/\/doi.org\/10.1186\/s13023-016-0513-0.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3985_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/jimd.12031","volume":"42","author":"R Posset","year":"2019","unstructured":"Posset R, Garbade SF, Boy N, Burlina AB, Dionisi-Vici C, Dobbelaere D, Garcia-Cazorla A, de Lonlay P, Teles EL, Vara R, et al. Transatlantic combined and comparative data analysis of 1095 patients with urea cycle disorders-A successful strategy for clinical research of rare diseases. J Inherit Metab Dis. 2019;42(1):93\u2013106. https:\/\/doi.org\/10.1002\/jimd.12031.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"3985_CR4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.jpeds.2012.06.065","volume":"162","author":"N Ah Mew","year":"2013","unstructured":"Ah Mew N, Krivitzky L, McCarter R, Batshaw M, Tuchman M. Clinical outcomes of neonatal onset proximal versus distal urea cycle disorders do not differ. J Pediatr. 2013;162(2):324-329.e321. https:\/\/doi.org\/10.1016\/j.jpeds.2012.06.065.","journal-title":"J Pediatr"},{"issue":"5","key":"3985_CR5","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s11011-018-0259-6","volume":"33","author":"J Kido","year":"2018","unstructured":"Kido J, Matsumoto S, Mitsubuchi H, Endo F, Nakamura K. Early liver transplantation in neonatal-onset and moderate urea cycle disorders may lead to normal neurodevelopment. Metab Brain Dis. 2018;33(5):1517\u201323. https:\/\/doi.org\/10.1007\/s11011-018-0259-6.","journal-title":"Metab Brain Dis"},{"issue":"1","key":"3985_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/siny.2001.0083","volume":"7","author":"JM Saudubray","year":"2002","unstructured":"Saudubray JM, Nassogne MC, de Lonlay P, Touati G. Clinical approach to inherited metabolic disorders in neonates: an overview. Semin Neonatol. 2002;7(1):3\u201315. https:\/\/doi.org\/10.1053\/siny.2001.0083.","journal-title":"Semin Neonatol"},{"issue":"5","key":"3985_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10545-011-9427-0","volume":"35","author":"J Kido","year":"2012","unstructured":"Kido J, Nakamura K, Mitsubuchi H, Ohura T, Takayanagi M, Matsuo M, Yoshino M, Shigematsu Y, Yorifuji T, Kasahara M, et al. Long-term outcome and intervention of urea cycle disorders in Japan. J Inherit Metab Dis. 2012;35(5):777\u201385. https:\/\/doi.org\/10.1007\/s10545-011-9427-0.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"3985_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10545-005-0303-7","volume":"28","author":"MC Nassogne","year":"2005","unstructured":"Nassogne MC, H\u00e9ron B, Touati G, Rabier D, Saudubray JM. Urea cycle defects: management and outcome. J Inherit Metab Dis. 2005;28(3):407\u201314. https:\/\/doi.org\/10.1007\/s10545-005-0303-7.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"3985_CR9","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ymgme.2020.10.013","volume":"131","author":"R Posset","year":"2020","unstructured":"Posset R, K\u00f6lker S, Gleich F, Okun JG, Gropman AL, Nagamani SCS, Scharre S, Probst J, Walter ME, Hoffmann GF, et al. Severity-adjusted evaluation of newborn screening on the metabolic disease course in individuals with cytosolic urea cycle disorders. Mol Genet Metab. 2020;131(4):390\u20137. https:\/\/doi.org\/10.1016\/j.ymgme.2020.10.013.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"3985_CR10","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/jimd.12100","volume":"42","author":"J H\u00e4berle","year":"2019","unstructured":"H\u00e4berle J, Burlina A, Chakrapani A, Dixon M, Karall D, Lindner M, Mandel H, Martinelli D, Pintos-Morell G, Santer R, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision. J Inherit Metab Dis. 2019;42(6):1192\u2013230. https:\/\/doi.org\/10.1002\/jimd.12100.","journal-title":"J Inherit Metab Dis"},{"issue":"8","key":"3985_CR11","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.transproceed.2015.09.020","volume":"47","author":"L Yu","year":"2015","unstructured":"Yu L, Rayhill SC, Hsu EK, Landis CS. Liver transplantation for urea cycle disorders: analysis of the United Network for Organ Sharing database. Transplant Proc. 2015;47(8):2413\u20138. https:\/\/doi.org\/10.1016\/j.transproceed.2015.09.020.","journal-title":"Transplant Proc"},{"issue":"1","key":"3985_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/petr.12196","volume":"18","author":"M Kasahara","year":"2014","unstructured":"Kasahara M, Sakamoto S, Horikawa R, Koji U, Mizuta K, Shinkai M, Takahito Y, Taguchi T, Inomata Y, Uemoto S, et al. Living donor liver transplantation for pediatric patients with metabolic disorders: the Japanese multicenter registry. Pediatr Transplant. 2014;18(1):6\u201315. https:\/\/doi.org\/10.1111\/petr.12196.","journal-title":"Pediatr Transplant"},{"issue":"1","key":"3985_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12785","volume":"48","author":"C Patterson","year":"2025","unstructured":"Patterson C, Gold A, So S, Kahnami L, Dworsky-Fried M, Mamak E, Rogers A, Schulze A, Ertl-Wagner B, Ng V, et al. Long-term neurodevelopmental outcomes following liver transplantation for metabolic disease-a single centre experience. J Inherit Metab Dis. 2025;48(1): e12785. https:\/\/doi.org\/10.1002\/jimd.12785.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"3985_CR14","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1600-6143.2006.01626.x","volume":"7","author":"C Bourdeaux","year":"2007","unstructured":"Bourdeaux C, Darwish A, Jamart J, Tri TT, Janssen M, Lerut J, Otte JB, Sokal E. de Ville de Goyet J, Reding R: Living-related versus deceased donor pediatric liver transplantation: a multivariate analysis of technical and immunological complications in 235 recipients. Am J Transplant. 2007;7(2):440\u20137. https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01626.x.","journal-title":"Am J Transplant"},{"issue":"1","key":"3985_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/TP.0b013e3181aaccb0","volume":"88","author":"Y Hashikura","year":"2009","unstructured":"Hashikura Y, Ichida T, Umeshita K, Kawasaki S, Mizokami M, Mochida S, Yanaga K, Monden M, Kiyosawa K. Donor complications associated with living donor liver transplantation in Japan. Transplantation. 2009;88(1):110\u20134. https:\/\/doi.org\/10.1097\/TP.0b013e3181aaccb0.","journal-title":"Transplantation"},{"key":"3985_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13023-014-0187-4","volume":"9","author":"E Mart\u00edn-Hern\u00e1ndez","year":"2014","unstructured":"Mart\u00edn-Hern\u00e1ndez E, Ald\u00e1miz-Echevarr\u00eda L, Castej\u00f3n-Ponce E, Pedr\u00f3n-Giner C, Couce ML, Serrano-Nieto J, Pintos-Morell G, B\u00e9langer-Quintana A, Mart\u00ednez-Pardo M, Garc\u00eda-Silva MT, et al. Urea cycle disorders in Spain: an observational, cross-sectional and multicentric study of 104 cases. Orphanet J Rare Dis. 2014;9:187. https:\/\/doi.org\/10.1186\/s13023-014-0187-4.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3985_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13023-018-0908-1","volume":"13","author":"S Bijarnia-Mahay","year":"2018","unstructured":"Bijarnia-Mahay S, H\u00e4berle J, Jalan AB, Puri RD, Kohli S, Kudalkar K, R\u00fcfenacht V, Gupta D, Maurya D, Verma J, et al. Urea cycle disorders in India: clinical course, biochemical and genetic investigations, and prenatal testing. Orphanet J Rare Dis. 2018;13(1):174. https:\/\/doi.org\/10.1186\/s13023-018-0908-1.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"3985_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248\u20139. https:\/\/doi.org\/10.1038\/nmeth0410-248.","journal-title":"Nat Methods"},{"issue":"4","key":"3985_CR19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz JM, Cooper DN, Schuelke M, Seelow D. Mutationtaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11(4):361\u20132. https:\/\/doi.org\/10.1038\/nmeth.2890.","journal-title":"Nat Methods"},{"issue":"7","key":"3985_CR20","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073\u201381. https:\/\/doi.org\/10.1038\/nprot.2009.86.","journal-title":"Nat Protoc"},{"key":"3985_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1750-1172-7-32","volume":"7","author":"J H\u00e4berle","year":"2012","unstructured":"H\u00e4berle J, Boddaert N, Burlina A, Chakrapani A, Dixon M, Huemer M, Karall D, Martinelli D, Crespo PS, Santer R, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis. 2012;7:32. https:\/\/doi.org\/10.1186\/1750-1172-7-32.","journal-title":"Orphanet J Rare Dis"},{"key":"3985_CR22","unstructured":"Ornithine Transcarbamylase Deficiency. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537257\/"},{"issue":"9","key":"3985_CR23","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/s41591-020-0966-5","volume":"26","author":"AN Adhikari","year":"2020","unstructured":"Adhikari AN, Gallagher RC, Wang Y, Currier RJ, Amatuni G, Bassaganyas L, Chen F, Kundu K, Kvale M, Mooney SD, et al. The role of exome sequencing in newborn screening for inborn errors of metabolism. Nat Med. 2020;26(9):1392\u20137. https:\/\/doi.org\/10.1038\/s41591-020-0966-5.","journal-title":"Nat Med"},{"issue":"1","key":"3985_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13023-022-02231-x","volume":"17","author":"X Huang","year":"2022","unstructured":"Huang X, Wu D, Zhu L, Wang W, Yang R, Yang J, He Q, Zhu B, You Y, Xiao R, et al. Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates. Orphanet J Rare Dis. 2022;17(1):66. https:\/\/doi.org\/10.1186\/s13023-022-02231-x.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"3985_CR25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.12231","volume":"6","author":"NB Gold","year":"2023","unstructured":"Gold NB, Adelson SM, Shah N, Williams S, Bick SL, Zoltick ES, Gold JI, Strong A, Ganetzky R, Roberts AE, et al. Perspectives of rare disease experts on newborn genome sequencing. JAMA Netw Open. 2023;6(5): e2312231. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.12231.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"3985_CR26","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ymgme.2022.06.006","volume":"136","author":"T Zhang","year":"2022","unstructured":"Zhang T, Duong P, Dayuha R, Collins CJ, Beckman E, Thies J, Chang I, Lam C, Sun A, Scott AI, et al. A rapid and non-invasive proteomic analysis using DBS and buccal swab for multiplexed second-tier screening of Pompe disease and Mucopolysaccharidosis type I. Mol Genet Metab. 2022;136(4):296\u2013305. https:\/\/doi.org\/10.1016\/j.ymgme.2022.06.006.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"3985_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jimd.12564","volume":"46","author":"GA Diaz","year":"2023","unstructured":"Diaz GA, Bechter M, Cederbaum SD. The role and control of arginine levels in arginase 1 deficiency. J Inherit Metab Dis. 2023;46(1):3\u201314. https:\/\/doi.org\/10.1002\/jimd.12564.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"3985_CR28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/gim.2011.1","volume":"14","author":"SC Nagamani","year":"2012","unstructured":"Nagamani SC, Erez A, Lee B. Argininosuccinate lyase deficiency. Genet Med. 2012;14(5):501\u20137. https:\/\/doi.org\/10.1038\/gim.2011.1.","journal-title":"Genet Med"},{"issue":"9","key":"3985_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.2007","volume":"10","author":"HA Chen","year":"2022","unstructured":"Chen HA, Hsu RH, Chang KL, Huang YC, Chiang YC, Lee NC, Hwu WL, Chiu PC, Chien YH. Asymptomatic ASS1 carriers with high blood citrulline levels. Mol Genet Genomic Med. 2022;10(9): e2007. https:\/\/doi.org\/10.1002\/mgg3.2007.","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"3985_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13023-023-02997-8","volume":"19","author":"B Siri","year":"2024","unstructured":"Siri B, Olivieri G, Lepri FR, Poms M, Goffredo BM, Commone A, Novelli A, H\u00e4berle J, Dionisi-Vici C. Father-to-daughter transmission in late-onset OTC deficiency: an underestimated mechanism of inheritance of an X-linked disease. Orphanet J Rare Dis. 2024;19(1):3. https:\/\/doi.org\/10.1186\/s13023-023-02997-8.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"3985_CR31","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/humu.20847","volume":"30","author":"K Engel","year":"2009","unstructured":"Engel K, H\u00f6hne W, H\u00e4berle J. Mutations and polymorphisms in the human argininosuccinate synthetase (ASS1) gene. Hum Mutat. 2009;30(3):300\u20137. https:\/\/doi.org\/10.1002\/humu.20847.","journal-title":"Hum Mutat"},{"issue":"1","key":"3985_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12929-024-01054-1","volume":"31","author":"N Gariballa","year":"2024","unstructured":"Gariballa N, Mohamed F, Badawi S, Ali BR. The double whammy of ER-retention and dominant-negative effects in numerous autosomal dominant diseases: significance in disease mechanisms and therapy. J Biomed Sci. 2024;31(1):64. https:\/\/doi.org\/10.1186\/s12929-024-01054-1.","journal-title":"J Biomed Sci"},{"issue":"1\u20132","key":"3985_CR33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ymgme.2019.07.009","volume":"128","author":"GM Enns","year":"2019","unstructured":"Enns GM, Porter MH, Francis-Sedlak M, Burdett A, Vockley J. Perspectives on urea cycle disorder management: results of a clinician survey. Mol Genet Metab. 2019;128(1\u20132):102\u20138. https:\/\/doi.org\/10.1016\/j.ymgme.2019.07.009.","journal-title":"Mol Genet Metab"},{"key":"3985_CR34","unstructured":"Nitrogen Metabolism and the Urea Cycle. https:\/\/themedicalbiochemistrypage.org\/nitrogen-metabolism.php"},{"key":"3985_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11175045","author":"E Mart\u00edn-Hern\u00e1ndez","year":"2022","unstructured":"Mart\u00edn-Hern\u00e1ndez E, Quijada-Fraile P, Correcher P, Meavilla S, S\u00e1nchez-Pintos P, de Las Heras Montero J, Blasco-Alonso J, Dougherty L, Marquez A, Pe\u00f1a-Quintana L, et al. Switching to glycerol phenylbutyrate in 48 patients with urea cycle disorders: clinical experience in Spain. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11175045.","journal-title":"J Clin Med"},{"issue":"5","key":"3985_CR36","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/jmd2.12386","volume":"64","author":"M Yeo","year":"2023","unstructured":"Yeo M, Rehsi P, Dorman M, Grunewald S, Baruteau J, Chakrapani A, Footitt E, Prunty H, McSweeney M. Clinical experience with glycerol phenylbutyrate in 20 patients with urea cycle disorders at a UK paediatric centre. JIMD Rep. 2023;64(5):317\u201326. https:\/\/doi.org\/10.1002\/jmd2.12386.","journal-title":"JIMD Rep"},{"key":"3985_CR37","doi-asserted-by":"publisher","unstructured":"[Guidelines for diagnosis, treatment and management of urea cycle disorders in China]. Zhonghua Er Ke Za Zhi 2022, 60(11):1118\u20131126. https:\/\/doi.org\/10.3760\/cma.j.cn112140-20220412-00319","DOI":"10.3760\/cma.j.cn112140-20220412-00319"},{"issue":"6","key":"3985_CR38","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/jimd.12415","volume":"44","author":"J Kido","year":"2021","unstructured":"Kido J, Matsumoto S, H\u00e4berle J, Inomata Y, Kasahara M, Sakamoto S, Horikawa R, Tanemura A, Okajima H, Suzuki T, et al. Role of liver transplantation in urea cycle disorders: report from a nationwide study in Japan. J Inherit Metab Dis. 2021;44(6):1311\u201322. https:\/\/doi.org\/10.1002\/jimd.12415.","journal-title":"J Inherit Metab Dis"},{"issue":"1\u20132","key":"3985_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ymgme.2014.06.005","volume":"113","author":"LC Burrage","year":"2014","unstructured":"Burrage LC, Jain M, Gandolfo L, Lee BH, Nagamani SC. Sodium phenylbutyrate decreases plasma branched-chain amino acids in patients with urea cycle disorders. Mol Genet Metab. 2014;113(1\u20132):131\u20135. https:\/\/doi.org\/10.1016\/j.ymgme.2014.06.005.","journal-title":"Mol Genet Metab"},{"key":"3985_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ani14060959","author":"W Liu","year":"2024","unstructured":"Liu W, Wang T, Zhao K, Hanigan MD, Lin X, Hu Z, Hou Q, Wang Y, Wang Z. Effects of individual essential amino acids on growth rates of young rats fed a low-protein diet. Animals. 2024. https:\/\/doi.org\/10.3390\/ani14060959.","journal-title":"Animals"},{"issue":"1","key":"3985_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/2052-0492-2-22","volume":"2","author":"MC Machado","year":"2014","unstructured":"Machado MC. Pinheiro da Silva F: hyperammonemia due to urea cycle disorders: a potentially fatal condition in the intensive care setting. J Intensive Care. 2014;2(1):22. https:\/\/doi.org\/10.1186\/2052-0492-2-22.","journal-title":"J Intensive Care"},{"issue":"4","key":"3985_CR42","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ymgme.2019.07.004","volume":"127","author":"GA Diaz","year":"2019","unstructured":"Diaz GA, Schulze A, Longo N, Rhead W, Feigenbaum A, Wong D, Merritt JL 2nd, Berquist W, Gallagher RC, Bartholomew D, et al. Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patients. Mol Genet Metab. 2019;127(4):336\u201345. https:\/\/doi.org\/10.1016\/j.ymgme.2019.07.004.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"3985_CR43","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1002\/hep.26058","volume":"57","author":"GA Diaz","year":"2013","unstructured":"Diaz GA, Krivitzky LS, Mokhtarani M, Rhead W, Bartley J, Feigenbaum A, Longo N, Berquist W, Berry SA, Gallagher R, et al. Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate. Hepatology. 2013;57(6):2171\u20139. https:\/\/doi.org\/10.1002\/hep.26058.","journal-title":"Hepatology"},{"key":"3985_CR44","unstructured":"Hyperammonemia. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557504\/"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03985-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03985-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03985-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T15:46:35Z","timestamp":1755099995000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03985-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3985"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03985-w","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the participants signed written informed consent and consented to participate in this investigation. The research protocol and process were approved by the Ethical Committee of The Children\u2019s Hospital of Zhejiang University School of Medicine (reference number: 2021-IRB-292). All methods used in the present study were performed following the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all patients or their legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"432"}}